Clinical Utility of Medical Exome Sequencing: Expanded Carrier Screening for Patients Seeking Assisted Reproductive Technology in China

被引:6
|
作者
Tong, Keya [1 ,2 ]
He, Wenbin [3 ,4 ,5 ]
He, Yao [1 ,2 ,6 ]
Li, Xiurong [3 ]
Hu, Liang [3 ]
Hu, Hao [3 ]
Lu, Guangxiu [3 ,4 ,5 ]
Lin, Ge [3 ,4 ,5 ]
Dong, Chang [7 ]
Zhang, Victor Wei [7 ]
Du, Juan [3 ,4 ,5 ]
Liu, Dongyun [1 ,2 ,6 ]
机构
[1] Chongqing Med Univ, Ctr Reprod Med, Women & Childrens Hosp, Chongqing, Peoples R China
[2] Women & Childrens Hosp Chongqing Med Univ, Chongqing Key Lab Human Embryo Engn, Chongqing, Peoples R China
[3] Natl Engn & Res Ctr Human Stem Cells, Changsha, Peoples R China
[4] Cent South Univ, Inst Reprod & Stem Cell Engn, Sch Basic Med Sci, Changsha, Peoples R China
[5] CITIC Xiangya, Genet Ctr Reprod & Genet Hosp, Changsha, Peoples R China
[6] Chongqing Med Univ, Chongqing Clin Res Ctr Reprod Med, Women & Childrens Hosp, Chongqing, Peoples R China
[7] AmCare Genom Lab, Guangzhou, Peoples R China
基金
中国博士后科学基金;
关键词
expanded carrier screening; Han Chinese ethnicity; assisted reproductive technology; preimplantation genetic testing; clinical utility; JOINT CONSENSUS RECOMMENDATION; AMERICAN-COLLEGE; P.V37I VARIANT; GENETICS; GENOMICS; POPULATION; MUTATIONS; STANDARDS; DISEASES; GJB2;
D O I
10.3389/fgene.2022.943058
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: Expanded carrier screening (ECS) is an effective method to identify at-risk couples (ARCs) and avoid birth defects. This study aimed to reveal the carrier spectrum in the Chinese population and to delineate an expanded carrier gene panel suitable in China.Methods: Medical exome sequencing (MES), including 4,158 disease-causing genes, was offered to couples at two reproductive centers. It was initially used as a diagnostic yield for potential patients and then used for ECS. Clinical information and ECS results were retrospectively collected.Results: A total of 2,234 couples, representing 4,468 individuals, underwent MES. In total, 254 individuals showed genetic disease symptoms, and 56 of them were diagnosed with genetic diseases by MES. Overall, 94.5% of them were carriers of at least one disease-causing variant. The most prevalent genes were GJB2 for autosomal recessive disorders and G6PD for X-linked diseases. The ARC rate was 9.80%, and couples were inclined to undergo preimplantation genetic testing when diseases were classified as "profound" or "severe."Conclusion: This study provided insight to establish a suitable ECS gene panel for the Chinese population. Disease severity significantly influenced reproductive decision-making. The results highlighted the importance of conducting ECS for couples before undergoing assisted reproductive technology.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Clinical exome sequencing for carrier screening in assisted reproductive technology and sperm donation
    Cai, He
    Bai, Haiyan
    Qiao, Sen
    Xue, Xia
    Shi, Wenhao
    Shi, Juanzi
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2025,
  • [2] Expanded carrier screening in Chinese patients seeking the help of assisted reproductive technology
    Xi, Yanping
    Chen, Guangquan
    Lei, Caixia
    Wu, Junping
    Zhang, Shuo
    Xiao, Min
    Zhang, Wenbi
    Zhang, Yueping
    Sun, Xiaoxi
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (09):
  • [3] The ethics of preconception expanded carrier screening in patients seeking assisted reproduction
    de Wert, Guido
    van der Hout, Sanne
    Goddijn, Mariette
    Vassena, Rita
    Frith, Lucy
    Vermeulen, Nathalie
    Eichenlaub-Ritter, Ursula
    HUMAN REPRODUCTION OPEN, 2021, 2021 (01)
  • [4] Clinical Utility of Expanded Carrier Screening: Reproductive Behaviors of At-Risk Couples
    Ghiossi, Caroline E.
    Goldberg, James D.
    Haque, Imran S.
    Lazarin, Gabriel A.
    Wong, Kenny K.
    JOURNAL OF GENETIC COUNSELING, 2018, 27 (03) : 616 - 625
  • [5] CLINICAL UTILITY OF EXPANDED CARRIER SCREENING: REPRODUCTIVE BEHAVIORS OF AT-RISK COUPLES.
    Wong, K. K.
    Ready, K.
    Lieber, C.
    Goldberg, J. D.
    Haque, I. S.
    Lazarin, G. A.
    Ghiossi, C.
    FERTILITY AND STERILITY, 2016, 106 (03) : E373 - E373
  • [6] Clinical Utility of Expanded Carrier Screening: Actionability and Outcomes
    Taber, Katie Johansen
    Beauchamp, Kyle
    Lazarin, Gabriel
    Arjunan, Aishwarya
    Goldberg, Jim
    OBSTETRICS AND GYNECOLOGY, 2019, 133 : 117S - 117S
  • [7] CLINICAL UTILITY OF PRECONCEPTION EXPANDED CARRIER SCREENING.
    Taber, K. Johansen
    Lazarin, G.
    Beauchamp, K.
    Arjunan, A.
    Muzzey, D.
    Wong, K.
    Goldberg, J.
    FERTILITY AND STERILITY, 2018, 110 (04) : E147 - E148
  • [8] Expanded carrier screening for inherited genetic disease using exome and genome sequencing
    Belnap, N.
    Ramsey, K.
    Abraham, A.
    Ryan, A.
    Rangasamy, S.
    Bonfitto, A.
    Naymik, M.
    Huentelman, M.
    Strom, S.
    Perry, D.
    Subramaniam, A.
    Grody, W. W.
    Szelinger, S.
    Narayanan, V.
    JOURNAL OF GENETIC COUNSELING, 2024,
  • [9] Clinical utility of periconception carrier screening by genome sequencing
    Boonsawat, Paranchai
    Baumer, Alessandra
    Ivanovski, Ivan
    Begemann, Anais
    Buerger, Olga
    Pfister, Surema
    Suter, Aude-Annick
    Zweier, Markus
    Kraemer, Dennis
    Papik, Michael
    Braun, Nils Christian
    Bahr, Angela
    Sticht, Heinrich
    Burkhardt, Tilo
    Rauch, Anita
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 356 - 356
  • [10] Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population
    Capalbo, A.
    Fabiani, M.
    Caroselli, S.
    Poli, M.
    Girardi, L.
    Patassini, C.
    Favero, F.
    Cimadomo, D.
    Vaiarelli, A.
    Simon, C.
    Rienzi, L. F.
    Ubaldi, F. M.
    HUMAN REPRODUCTION, 2021, 36 (07) : 2050 - 2061